Skip to main content
. Author manuscript; available in PMC: 2015 Nov 9.
Published in final edited form as: Am J Med Genet A. 2015 Jan 13;0(2):324–330. doi: 10.1002/ajmg.a.36903

Table I.

Characteristics of Infants with DS Evaluated for Obstructive Sleep Apnea at the Down Syndrome Program at Riley Hospital for Children, August 2005 to December 2011

Full Sample (n=177) Infants with PSG (n=59) Infants with no identified PSG (n=118)
Mean Estimated Gestational Age (weeks) 37.5 ± 2.1 37 ± 2.4 37.8 ± 1.9
Male n=93 n=32 n=61
Female n=84 n=26 n=58
Prematurity1* n=37 (21%) n=18 (30%) n=19 (16%)
CHD2* n=73 (41%) n=30 (50%) n=43 (36%)
GI Abnormalities3*,** n=102 (57%) n=41 (69%) n=61 (51%)
GERD4* n=66 (37%) n=29 (49%) n=37 (31%)
Constipation n=43 (24%) n=21 (36%) n=22 (19%)
Duodenal Atresia n=10 (5%) n=4 (7%) n=6 (5%)
Duodenal Stenosis n=3 (1%) n=1 (2%) n=2 (2%)
Tracheoesophageal Fistula n=0 (0%) n=0 (0%) n=0 (0%)
Malrotation n=3(1%) n=2 (3%) n=1 (1%)
Hirschsprung Disease n=12 (7%) n=6 (10%) n=6 (5%)
Dysphagia* n=89 (50%) n=42 (71%) n=47 (40%)
1

Prematurity in estimated gestational age (weeks)

2

Congenital heart disease including atrial septal defects, ventricular septal defects, atrioventricular canal defects, tetralogy of Fallot, aortic coarctation, and patent ductus arteriosus

3

Includes the presence of one or more of the following structural or functional gastrointestinal abnormalities: gastroesophageal reflux disease, constipation, duodenal atresia, duodenal stenosis, tracheoesophageal fistula, malrotation, and Hirschsprung disease.

4

Gastroesophageal reflux disease

*

Denotes statistically significant correlate of obstructive sleep apnea, defined by AHI level of 2 or greater.

**

Denotes statistical significance of odds ratio P=0.002.